About Cadlay Pharma
Cadlay Pharma is a Healthcare company based in Solan (India) founded in 2020. Pharmaceutical manufacturing and quality assurance services in India. The company has 19 employees. Its Indian entity Cadlay Pharma Private Limited reported revenue of ₹3.27 Cr. Cadlay Pharma offers products and services including CAD-HES 3% and Nitromin Infusion. Its focus areas include Pharmaceuticals, Drug Manufacturing, Generic Drugs and Medical Devices.
Company details
Cadlay Pharma is identified as an ISO 9001:2015 certified company based in Baddi, Himachal Pradesh. Products are procured under strict international guidelines and are subjected to various quality tests to ensure optimal productivity and genuine standards. Ethical business policies and transparent dealings are maintained, with high-quality pharmaceutical items being offered at reasonable rates. The company focuses on maintaining standardized quality through assurance tests, making its products widely recognized in the market.
- Headquarters Solan, India
- Employees 19
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website cadlay.in
- Legal Name Cadlay Pharma Private Limited
- Date of Incorporation 21 Nov, 2019
- Jurisdiction Baddi, Himachal Pradesh, India
- Annual Revenue₹3.27 Cr
FY 2024 · +25% YoY
- Net Profit₹2.5 Lakh
FY 2024 · 1% margin
- EBITDA₹11.6 Lakh
FY 2024 · 4% margin
- Employee Count19
Associated legal entities of Cadlay Pharma
Cadlay Pharma operates through Cadlay Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Cadlay Pharma Private Limited CIN U74999HP2019PTC007708 | Active | 21 Nov 2019 | Nalagarh, Himachal Pradesh | ₹3.3 Cr | 19 | 3 | View details |
Products & Services of Cadlay Pharma
Cadlay Pharma offers a comprehensive portfolio of products and services, including CAD-HES 3% and Nitromin Infusion.
Infusions are manufactured for medical applications under quality guidelines.
Infusions are provided for therapeutic uses following international standards.
Board of directors of Cadlay Pharma Private Limited (Cadlay Pharma)
Cadlay Pharma Private Limited is the primary company behind Cadlay Pharma. The board of Cadlay Pharma Private Limited currently have 3 directors; the longest-serving is Sanjeev Kumar Sharma, appointed in 2019.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sanjeev Kumar Sharma DIN 08618596 | Director | 21 Nov 2019 | 6 yrs 11 mo | Cadlay Pharma Private Limited |
| Dilip Kumar Ghosh DIN 08618597 | Director | 21 Nov 2019 | 6 yrs 11 mo | Cadlay Pharma Private Limited |
| Chitra Sharma DIN 08884995 | Director | 12 Sep 2020 | 6 yrs 1 mo | Cadlay Pharma Private Limited |
Financials of Cadlay Pharma
Figures of Cadlay Pharma Private Limited, the primary company behind Cadlay Pharma, for FY 2024. Revenue was ₹3.27 Cr (+25% year on year). Net profit was ₹2.5 Lakh (1% margin). EBITDA was ₹11.6 Lakh (4% margin).
- ₹3.27 CrRevenue · FY 2024 · +25% YoY
- ₹2.5 LakhNet profit · 1% margin
- ₹11.6 LakhEBITDA · 4% margin
- ₹1 LakhPaid-up capital
- 19Employees (provident fund records)
Balance sheet, profit and loss, cash flow and ratios of Cadlay Pharma Private Limited are on its company page.
Detailed financial statements for Cadlay Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Cadlay Pharma
Websites that share an audience with Cadlay Pharma (cadlay.in).
Websites whose visitors overlap most with Cadlay Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| acmegenerics.in | 96% | 1.9K | #7,893,927 | View details | |
| swissgarnier.com | 90% | 1.1K | #13,288,880 | View details | |
| drdpharma.in | 86% | 1.7K | #8,901,988 | View details | |
| galpha.com | 33% | 7K | #5,128,365 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cadlay Pharma
Cadlay Pharma was founded in 2020.
Cadlay Pharma is headquartered in Solan, India. It is registered at Solan, Himachal Pradesh, India.
Cadlay Pharma has 19 employees.
The primary company behind Cadlay Pharma, Cadlay Pharma Private Limited, reported revenue of ₹3.27 Cr for FY 2024, up 25% year on year.
Cadlay Pharma is identified as an ISO 9001:2015 certified company based in Baddi, Himachal Pradesh. Products are procured under strict international guidelines and are subjected to various quality tests to ensure optimal productivity and genuine standards. Ethical business policies and transparent dealings are maintained, with high-quality pharmaceutical items being offered at reasonable rates. The company focuses on maintaining standardized quality through assurance tests, making its products widely recognized in the market.
Cadlay Pharma offers CAD-HES 3% and Nitromin Infusion.
Cadlay Pharma operates through Cadlay Pharma Private Limited.
The legal entities of Cadlay Pharma currently have 3 directors, including Chitra Sharma, Sanjeev Kumar Sharma, Dilip Kumar Ghosh.